Đang chuẩn bị liên kết để tải về tài liệu:
Pharmaceutical Substances Syntheses, Patents, Applications - Part 196

Pharmaceutical Substances Syntheses, Patents, Applications - Part 196. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers. | Suprofen S 1951 Suprofen ATC M01AE07 Use anti-inflammatory analgesic R.N 40828-46-4 MF CuHnO3S MW 260.31 EINECS 255-096-9 LD50 185 mg kg M i.v. 590 mg kg M p.o. 226 mg kg R i.v. 70.6 mg kg R p.o. 160 mg kg dog p.o. CN ot-methyL4- 2 thienyIcarbonyl bcnzeneacetic acid AlCI-j COOH thiophene-Z-carboxylic odd SOCI2 thionyl chloride thiophene-2-carbonyl chloride -------------- fluorobenzene aluminum chloride 0 H C 0 o ch3 O diethyl methylmolonate tniophene 4-ethylbenzoyl tetrachloride 4-ethylphenyl 2-thienyl ketone II chloride Suprofen Reference s DOS2353 357 Janssen appl. 24.10.1973 USA-prior. 24.10.1972 10.9.1973 23.3.1974 . Daele P.G.H. van et al. Arzneim.-Forsch. ARZNAD 25 1495 1975 . Formulation s cps. 200 mg Trade Name s GB Suprol Cilag wfm 1 Erdöl Herdel wfm Masterfin Dompe wfm Sufenide Italfarmaco wfm Suprol Cilag wfm J Lindral Taiho Lindrax Taiho Mexaron Toyo Yozo Sulplotin Ichikawa Labs USA Suprol Ortho wfm 1952 S Surfactant TA Surfactant TA Beractant ATC R07A Use surfactant for treatment of respiratory distress syndrome RN 108778-82-1 MF unspecified MW unspecified LD 0 2000 mg kg M i.p. 3000 mg kg M p.o. CN beractant Production comprises a extracting mammalian lung slices with an electrolyte soln. NaCl b centrifuging the extract to collect a crude precipitation c suspending the precipitate in water adjusting specific gravity of the suspension with CaCl2 and centrifuging the suspension to separate upper emulsion layer d dialysing the emulsion and freeze-drying the dialysed soln. e treating the resultant powder with ethyl acetate collecting the insoluble material and extracting the insoluble material with an organic solvent CH3OH CHC13 and f concentrating the extract to give a solid. Reference s DE 3 021 006 Tokyo Tanabe appl. 30.5.1980 J-prior. 2.6.1979 . US 4 397 839 Tokyo Tanabe 9.8.1983 J-prior. 10.9.1981 . Formulations vial 120mg lyo. Trade Name s J Surfacten Tokyo Tanabe 1987 Suxamethonium chloride ATC M03AB01 Succinylcholine chloride Use muscle relaxant .